Interim guidelines for biosafety and COVID-19 : interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Interim guidelines for biosafety and COVID-19 : interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)
Filetype[PDF-108.58 KB]


Details:
  • Description:
    Updated Sept. 19, 2020 Summary of Recent Changes Revisions made on September 19, 2020 include: • New link under Resources to DLS Preparing and Supporting Laboratories Responding to COVID-19 page Revisions made on August 7, 2020 include: • Standard Precautions Revisions made on July 16, 2020 include: • Added DOT resources to Specimen Packing and Shipping and Resource section Revisions made on July 13, 2020 to update: • Language for virus isolation Revisions made on June 3, 2020 include: • Added anatomic pathology guidance for COVID-19 • Updated Point-of-Care testing guidance for COVID-19 Revisions made on May 11, 2020 include recommendations for: • Point-of-Care testing guidance for COVID-19 Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2. Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection. Such specimens should be labeled accordingly, and the laboratory should be alerted to ensure proper specimen handling. General and specific biosafety guidelines for handling SARS-CoV-2 specimens are provided below. For additional information on handling SARS-CoV-2 specimens, refer to the Laboratory Biosafety Frequently Asked Questions.
  • Content Notes:
    General Guidance -- Routine Viral Testing -- Anatomic Pathology -- Decentralized and Point of Care Testing -- Procedures with a High Likelihood to Generate Droplets or Aerosols -- Environmental Specimen Testing -- Virus Isolation -- Decontamination -- Laboratory Waste Management -- Specimen Packing and Shipping -- Resources.
  • Document Type:
  • Main Document Checksum:
  • File Type:
No Related Documents.

You May Also Like: